Pacira BioSciences (PCRX)
(Delayed Data from NSDQ)
$20.21 USD
+0.84 (4.34%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $20.39 +0.18 (0.89%) 5:24 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | 0.73 |
EPS Last Quarter | 0.62 |
Last EPS Surprise | -3.12% |
ABR | 1.56 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 2.94 |
Next Year | 3.75 |
EPS (TTM) | 3.01 |
P/E (F1) | 6.59 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 173.28M | 171.50M | 696.18M | 763.04M |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 174.50M | 176.27M | 697.79M | 780.20M |
Low Estimate | 172.60M | 168.57M | 693.88M | 748.89M |
Year ago Sales | 169.47M | 163.93M | 674.98M | 696.18M |
Year over Year Growth Est. | 2.25% | 4.62% | 3.14% | 9.60% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.73 | 0.72 | 2.94 | 3.75 |
# of Estimates | 7 | 7 | 7 | 7 |
Most Recent Consensus | 0.68 | 0.68 | 2.86 | 3.92 |
High Estimate | 0.83 | 0.87 | 3.22 | 4.29 |
Low Estimate | 0.67 | 0.64 | 2.74 | 3.38 |
Year ago EPS | 0.78 | 0.72 | 2.81 | 2.94 |
Year over Year Growth Est. | -6.41% | 0.00% | 4.63% | 27.45% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.73 | 0.72 | 2.94 | 3.75 |
7 Days Ago | 0.73 | 0.72 | 2.94 | 3.75 |
30 Days Ago | 0.73 | 0.72 | 2.94 | 3.75 |
60 Days Ago | 0.68 | 0.67 | 2.71 | 3.43 |
90 Days Ago | 0.68 | 0.66 | 2.72 | 3.39 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.73 | 0.72 | 2.94 | 3.75 |
Zacks Consensus Estimate | 0.73 | 0.72 | 2.94 | 3.75 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.62 | 0.89 | 0.72 | 0.78 | NA |
Estimate | 0.64 | 0.89 | 0.84 | 0.81 | NA |
Difference | -0.02 | 0.00 | -0.12 | -0.03 | -0.04 |
Surprise | -3.12% | 0.00% | -14.29% | -3.70% | -5.28% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more